article Open AccessTop 1% cited
Toward a Global View of Alcohol, Tobacco, Cannabis, and Cocaine Use: Findings from the WHO World Mental Health Surveys
PLoS Medicine · 2008 · Vol. 5(7) · pp. e141–e141
Louisa Degenhardt✉(UNSW Sydney)Wai‐Tat Chiu(Harvard University)Nancy A. Sampson(Harvard University)Ronald C. Kessler(Harvard University)James C. Anthony(Michigan United)Matthias C. Angermeyer(Leipzig University)Ronny Bruffaerts(KU Leuven)Giovanni de Girolamo(Agenzia Sanitaria e Sociale Regionale)Oye Gureje(University College Hospital, Ibadan)Yueqin Huang(Peking University)Aimée Karam(Institute for Development, Research, Advocacy and Applied Care)Stanislav KostyuchenkoJ.P. Lépine(Hôpital Fernand-Widal)María Elena Medina MoraYehuda Neumark(Hebrew University of Jerusalem)Johan Ormel(University Medical Center Groningen)Alejandra Pinto‐MezaJosé Posada‐VillaDan J. Stein(University of Cape Town)Tadashi Takeshima(National Institute of Mental Health)J. Elisabeth Wells(Christchurch Clinical Studies Trust)
Abstract
Globally, drug use is not distributed evenly and is not simply related to drug policy, since countries with stringent user-level illegal drug policies did not have lower levels of use than countries with liberal ones. Sex differences were consistently documented, but are decreasing in more recent cohorts, who also have higher levels of illegal drug use and extensions in the period of risk for initiation.
Substance Abuse Treatment and OutcomesMental Health Treatment and AccessCannabis and Cannabinoid ResearchCIDICannabisMental healthMedicineDemographyCohortEnvironmental healthChinaEpidemiologyPublic health
MeSH terms
AdolescentAdultCannabisMarijuana AbuseFemaleHealth SurveysHumansMaleMental HealthTobacco Use DisorderGlobal HealthWorld Health OrganizationCohort StudiesCocaine-Related DisordersAlcohol-Related Disorders
Funding
- Robert Wood Johnson Foundation
- John W. Alden Trust
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- World Health Organization
- University of Michigan
- Australian Government
- European Commission
- Generalitat de Catalunya
- Bundesministerium für Gesundheit
- National Insurance Institute of Israel
- Ministry of Health, Labour and Welfare
- Regione Piemonte
- Substance Abuse and Mental Health Services Administration
- Pfizer Foundation
- Pan American Health Organization
- Medical Research Council
- National Health and Medical Research Council
- Instituto de Salud Carlos III
- Departament de Salut, Generalitat de Catalunya
- National Institute of Mental Health
- National Institute on Drug Abuse
- Fogarty International Center
- Cilag
Citations
799
FWCI
28.88
field-weighted impact
References
55
Percentile
100%
vs. same field & year
Citations per year
Cited by
Birth cohort trends in the global epidemiology of alcohol use and alcohol-related harms in men and women: systematic review and metaregression
BMJ Open · 2016 · 443 citations
How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective <i>versus</i> retrospective ascertainment
Psychological Medicine · 2009 · 903 citations
The co‐occurring use and misuse of cannabis and tobacco: a review
Addiction · 2012 · 523 citations
Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis
Drug and Alcohol Dependence · 2015 · 897 citations
References
Applied logistic regression
Choice Reviews Online · 1990 · 35,647 citations
Early onset cannabis use and psychosocial adjustment in young adults
Addiction · 1997 · 484 citations
The International Pilot Study of Schizophrenia
Schizophrenia Bulletin · 1974 · 540 citations
International Classification of Diseases
Gut · 1978 · 2,920 citations
Acta Psychiatrica Scandinavica
Acta Psychiatrica Scandinavica · 2010 · 384 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
